
    
      The study will evaluate two parallel groups of 200 adults ≥ 65 YOA; one group (Prev-Zvax)
      with a previous Zostavax® vaccination at least 5 years earlier, versus the other group
      without a previous Zostavax® vaccination (No prev-Zvax). The goal of this study is to
      generate immunogenicity, safety and reactogenicity data for the respective vaccines.
    
  